Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01692587 · ClinicalTrials.gov registry record · NA
Does Protein Restriction Inhibit Prostrate Cancer Growth
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT01692587 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 65 participants.
The verdict
NCT01692587, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
The Purpose of the Protein Study is to investigate whether a reduced protein diet can inhibit the growth of prostate cancer in humans. The Investigators hypothesis is that a reduced protein diet will inhibit expression of genes that are involved in the growth of prostate cancer.
Interventions
- OTHER Protein restrictive diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2011-01 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01692587
The ClinicalTrials.gov registry entry for NCT01692587 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Protein restrictive diet is the first listed.
NCT01692587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01692587 about?
NCT01692587 is a clinical study titled "Does Protein Restriction Inhibit Prostrate Cancer Growth". The Purpose of the Protein Study is to investigate whether a reduced protein diet can inhibit the growth of prostate cancer in humans. The Investigators hypothesis is that a reduced protein diet will inhibit expression of genes that are involved in the growth of prostate cancer.
What is the current status of trial NCT01692587?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2011-01. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01692587?
The interventions under investigation include: Protein restrictive diet (OTHER).
Who is sponsoring clinical trial NCT01692587?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.